This company is showing great vital signs. They have engaged in a nationwide advertising program and are hiring agressively following a period of consolidation last year. The earnings report due out in early May will be the inflection point for a dramatic rise in price.
the massive short-interest suggests someone told wallstreet the sales are getting weaker for Provenge and better for Xtandi. of course, the direct-to-consumer tv ads is another sign of desperation the Provenge sales have peaked.
Great vital: burning cash and stagnant sales,(may Decrease)? Inflection my ash, this is still at $4.50 can easily inflect downward, thats a bend for ya! Think really, really , really hard about what they are advertising and to who? Seems to be a last ditch effort.
The market knows EU approval is almost a certainty, yet here you at @ $4.57. My guess is, that EU approval is already factored into the $4.57. Of course it is going to be good for a small pop/rally when it's official, but history suggests it will be a short one.